US Stock MarketDetailed Quotes

Apogee Therapeutics (APGE)

Watchlist
  • 86.470
  • +0.860+1.00%
Close Apr 27 16:00 ET
  • 85.340
  • -1.130-1.31%
Pre 08:06 ET
5.35BMarket Cap-20.49P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apogee Therapeutics (APGE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-32.88%-227.45M
7.42%-62.69M
-27.59%-54.26M
-111.70%-62.03M
-53.23%-48.48M
-128.96%-171.17M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.3M
-199.67%-31.64M
Net income from continuing operations
-40.46%-255.84M
-3.23%-69.39M
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
Depreciation and amortization
650.26%1.42M
434.21%406K
745.83%406K
1,008.33%399K
613.79%207K
--189K
--76K
--48K
--36K
--29K
Other non cash items
117.06%3.68M
26.02%959K
142.89%940K
228.93%921K
222.18%857K
1,847.13%1.69M
--761K
--387K
--280K
--266K
Change In working capital
-673.13%-15.48M
18.49%-4.86M
-122.47%-837K
-543.39%-6.84M
-124.60%-2.95M
-132.79%-2M
-336.16%-5.96M
1,290.10%3.73M
-51.84%1.54M
-289.19%-1.31M
-Change in prepaid assets
65.36%-2.11M
375.50%1.64M
25.03%-2.11M
-109.15%-2.54M
161.22%895K
-118.31%-6.08M
-196.60%-596K
-95.34%-2.81M
36.82%-1.21M
-3,222.73%-1.46M
-Change in payables and accrued expense
-117.70%-924K
-9.85%-5.57M
-64.14%2.44M
-159.07%-1.81M
873.54%4.01M
-43.67%5.22M
-322.04%-5.07M
505.24%6.81M
-40.14%3.07M
-44.17%412K
-Change in other current assets
-8,628.87%-8.47M
356.25%73K
-293.48%-181K
-2,165.67%-1.52M
---6.84M
9.35%-97K
114.95%16K
---46K
---67K
--0
-Change in other current liabilities
-280.96%-3.98M
-224.92%-1M
-333.19%-992K
-297.95%-971K
-285.55%-1.01M
-287.04%-1.05M
-14.44%-309K
---229K
---244K
---263K
Cash from discontinued investing activities
Operating cash flow
-32.88%-227.45M
7.42%-62.69M
-27.59%-54.26M
-111.70%-62.03M
-53.23%-48.48M
-128.96%-171.17M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.3M
-199.67%-31.64M
Investing cash flow
Cash flow from continuing investing activities
40.23%-179.57M
-722.48%-288.63M
112.26%17.95M
152.54%78.13M
125.09%12.98M
-9.69%-300.46M
216.82%46.37M
37.50%-146.38M
-148.71M
-51.74M
Net PPE purchase and sale
-346.79%-5.15M
-6,300.00%-62K
--0
-1,405.88%-768K
-1,129.91%-4.32M
-589.82%-1.15M
100.60%1K
---751K
---51K
---351K
Net investment purchase and sale
41.72%-174.43M
-722.36%-288.56M
112.32%17.95M
153.07%78.89M
133.66%17.3M
-9.34%-299.31M
217.31%46.37M
37.82%-145.63M
---148.66M
---51.39M
Cash from discontinued investing activities
Investing cash flow
40.23%-179.57M
-722.48%-288.63M
112.26%17.95M
152.54%78.13M
125.09%12.98M
-9.69%-300.46M
216.82%46.37M
37.50%-146.38M
---148.71M
---51.74M
Financing cash flow
Cash flow from continuing financing activities
-19.92%396.49M
745.32%374.95M
5,053.52%19.74M
886.67%1.18M
-99.86%622K
56.98%495.11M
20,924.41%44.36M
-99.88%383K
91.15%-150K
450.52M
Net common stock issuance
-21.04%389.63M
750.61%370.25M
--19.38M
--0
--0
56.47%493.48M
20,535.68%43.53M
--0
---541K
--450.5M
Proceeds from stock option exercised by employees
321.65%6.86M
467.39%4.7M
-7.05%356K
201.79%1.18M
2,491.67%622K
--1.63M
--828K
--383K
--391K
--24K
Cash from discontinued financing activities
Financing cash flow
-19.92%396.49M
745.32%374.95M
5,053.52%19.74M
886.67%1.18M
-99.86%622K
56.98%495.11M
20,924.41%44.36M
-99.88%383K
91.15%-150K
--450.52M
Net cash flow
Beginning cash position
19.79%142.08M
-9.37%107.91M
-59.53%124.49M
-77.93%107.21M
19.79%142.08M
-21.91%118.61M
-36.75%119.07M
145.94%307.59M
243.69%485.75M
-21.91%118.61M
Current changes in cash
-144.88%-10.53M
2.72%23.64M
91.21%-16.57M
109.70%17.28M
-109.50%-34.87M
170.53%23.47M
133.03%23.01M
-398.29%-188.52M
-995.41%-178.16M
3,577.70%367.14M
End cash Position
-7.41%131.55M
-7.41%131.55M
-9.37%107.91M
-59.53%124.49M
-77.93%107.21M
19.79%142.08M
19.79%142.08M
-36.75%119.07M
145.94%307.59M
243.69%485.75M
Free cash flow
-34.97%-232.6M
7.33%-62.75M
-25.37%-54.26M
-113.95%-62.8M
-65.05%-52.79M
-129.99%-172.33M
-126.31%-67.71M
-117.68%-43.28M
-101.45%-29.35M
-202.99%-31.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -32.88%-227.45M7.42%-62.69M-27.59%-54.26M-111.70%-62.03M-53.23%-48.48M-128.96%-171.17M-127.58%-67.71M-113.90%-42.52M-101.10%-29.3M-199.67%-31.64M
Net income from continuing operations -40.46%-255.84M-3.23%-69.39M-32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M
Depreciation and amortization 650.26%1.42M434.21%406K745.83%406K1,008.33%399K613.79%207K--189K--76K--48K--36K--29K
Other non cash items 117.06%3.68M26.02%959K142.89%940K228.93%921K222.18%857K1,847.13%1.69M--761K--387K--280K--266K
Change In working capital -673.13%-15.48M18.49%-4.86M-122.47%-837K-543.39%-6.84M-124.60%-2.95M-132.79%-2M-336.16%-5.96M1,290.10%3.73M-51.84%1.54M-289.19%-1.31M
-Change in prepaid assets 65.36%-2.11M375.50%1.64M25.03%-2.11M-109.15%-2.54M161.22%895K-118.31%-6.08M-196.60%-596K-95.34%-2.81M36.82%-1.21M-3,222.73%-1.46M
-Change in payables and accrued expense -117.70%-924K-9.85%-5.57M-64.14%2.44M-159.07%-1.81M873.54%4.01M-43.67%5.22M-322.04%-5.07M505.24%6.81M-40.14%3.07M-44.17%412K
-Change in other current assets -8,628.87%-8.47M356.25%73K-293.48%-181K-2,165.67%-1.52M---6.84M9.35%-97K114.95%16K---46K---67K--0
-Change in other current liabilities -280.96%-3.98M-224.92%-1M-333.19%-992K-297.95%-971K-285.55%-1.01M-287.04%-1.05M-14.44%-309K---229K---244K---263K
Cash from discontinued investing activities
Operating cash flow -32.88%-227.45M7.42%-62.69M-27.59%-54.26M-111.70%-62.03M-53.23%-48.48M-128.96%-171.17M-127.58%-67.71M-113.90%-42.52M-101.10%-29.3M-199.67%-31.64M
Investing cash flow
Cash flow from continuing investing activities 40.23%-179.57M-722.48%-288.63M112.26%17.95M152.54%78.13M125.09%12.98M-9.69%-300.46M216.82%46.37M37.50%-146.38M-148.71M-51.74M
Net PPE purchase and sale -346.79%-5.15M-6,300.00%-62K--0-1,405.88%-768K-1,129.91%-4.32M-589.82%-1.15M100.60%1K---751K---51K---351K
Net investment purchase and sale 41.72%-174.43M-722.36%-288.56M112.32%17.95M153.07%78.89M133.66%17.3M-9.34%-299.31M217.31%46.37M37.82%-145.63M---148.66M---51.39M
Cash from discontinued investing activities
Investing cash flow 40.23%-179.57M-722.48%-288.63M112.26%17.95M152.54%78.13M125.09%12.98M-9.69%-300.46M216.82%46.37M37.50%-146.38M---148.71M---51.74M
Financing cash flow
Cash flow from continuing financing activities -19.92%396.49M745.32%374.95M5,053.52%19.74M886.67%1.18M-99.86%622K56.98%495.11M20,924.41%44.36M-99.88%383K91.15%-150K450.52M
Net common stock issuance -21.04%389.63M750.61%370.25M--19.38M--0--056.47%493.48M20,535.68%43.53M--0---541K--450.5M
Proceeds from stock option exercised by employees 321.65%6.86M467.39%4.7M-7.05%356K201.79%1.18M2,491.67%622K--1.63M--828K--383K--391K--24K
Cash from discontinued financing activities
Financing cash flow -19.92%396.49M745.32%374.95M5,053.52%19.74M886.67%1.18M-99.86%622K56.98%495.11M20,924.41%44.36M-99.88%383K91.15%-150K--450.52M
Net cash flow
Beginning cash position 19.79%142.08M-9.37%107.91M-59.53%124.49M-77.93%107.21M19.79%142.08M-21.91%118.61M-36.75%119.07M145.94%307.59M243.69%485.75M-21.91%118.61M
Current changes in cash -144.88%-10.53M2.72%23.64M91.21%-16.57M109.70%17.28M-109.50%-34.87M170.53%23.47M133.03%23.01M-398.29%-188.52M-995.41%-178.16M3,577.70%367.14M
End cash Position -7.41%131.55M-7.41%131.55M-9.37%107.91M-59.53%124.49M-77.93%107.21M19.79%142.08M19.79%142.08M-36.75%119.07M145.94%307.59M243.69%485.75M
Free cash flow -34.97%-232.6M7.33%-62.75M-25.37%-54.26M-113.95%-62.8M-65.05%-52.79M-129.99%-172.33M-126.31%-67.71M-117.68%-43.28M-101.45%-29.35M-202.99%-31.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.72%
Sample Name
Sample Code
 +8.47%
Sample Name
Sample Code
 +7.98%
4
VanEck Oil Services ETF
OIH
+5.58%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.68%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.58%
Sample Name
Sample Code
 +6.89%
Sample Name
Sample Code
 +5.36%
4
Chagee Holdings
CHA
+3.18%
5
Qifu Technology
QFIN
+0.60%
View More
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -